NCT07200817 Neutrophils to Lymphocytes and Platelets Ratio, Procalcitonin, and Total Leucocytic Count as Indicators of Prognostic Outcome in Septic Patients in the Intensive Care Unit.
| NCT ID | NCT07200817 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ain Shams University |
| Condition | Neutrophils to Lymphocytes |
| Study Type | OBSERVATIONAL |
| Enrollment | 290 participants |
| Start Date | 2024-09-20 |
| Primary Completion | 2026-03-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 290 participants in total. It began in 2024-09-20 with a primary completion date of 2026-03-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare Neutrophil to Lymphocyte and Platelet Ratio, Procalcitonin, and Total Leucocyte Count as indicators of prognostic outcome in septic patients in the intensive care unit.
Eligibility Criteria
Inclusion Criteria: * Age from 18 to 70 years old. * Both sexes. * Septic patients (under the third international consensus definitions of sepsis and septic shock). Exclusion Criteria: * Pregnancy * Malignancy * On immunosuppressive therapy * Hematological Disorders * Major Trauma * Major Burns * Child-Pugh Class C Liver Cirrhosis * On Hemodialysis
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07200817 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Neutrophils to Lymphocytes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07200817 currently recruiting?
Yes, NCT07200817 is actively recruiting participants. Contact the research team at MICHAELFARAG@med.asu.edu.eg for enrollment information.
Where is the NCT07200817 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07200817 clinical trial?
NCT07200817 is sponsored by Ain Shams University. The trial plans to enroll 290 participants.